Based on the antitumor activity of CXCL14 through immune activation in several cancers [32,40,42,43,45,65,66], we propose that CXCL14 could be used in cancer immunotherapy, particularly in treating HPV+ cancers [40,42]. The gene discussed is CXCL14; the disease is cancer.